Asensus Surgical, Inc. Share Price

Equities

ASXC

US04367G1031

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
0.249 USD +3.32% Intraday chart for Asensus Surgical, Inc. -0.40% -21.92%
Sales 2024 * 12.3M 1.03B Sales 2025 * 22.21M 1.85B Capitalization 67.72M 5.65B
Net income 2024 * -62M -5.17B Net income 2025 * -55M -4.59B EV / Sales 2024 * 5.51 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 3.05 x
P/E ratio 2024 *
-1.35 x
P/E ratio 2025 *
-1.72 x
Employees 208
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.32%
1 week-0.40%
Current month+8.26%
1 month+8.26%
3 months-7.78%
6 months+11.46%
Current year-21.92%
More quotes
1 week
0.24
Extreme 0.2359
0.26
1 month
0.21
Extreme 0.208
0.29
Current year
0.21
Extreme 0.208
0.38
1 year
0.20
Extreme 0.204
0.70
3 years
0.20
Extreme 0.204
3.75
5 years
0.20
Extreme 0.204
27.69
10 years
0.20
Extreme 0.204
90.74
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 01/15/01
Director of Finance/CFO 57 24/20/24
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 68 01/05/01
Director/Board Member 59 22/21/22
Founder 70 19/98/19
More insiders
Date Price Change Volume
26/24/26 0.249 +3.32% 610,940
25/24/25 0.241 -0.82% 1,477,813
24/24/24 0.243 -2.41% 1,105,403
23/24/23 0.249 -0.40% 1,203,148
22/24/22 0.25 0.00% 912,552

Delayed Quote Nyse, April 27, 2024 at 01:30 am IST

More quotes
Asensus Surgical, Inc. is a medical device company digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery to enable surgeons to deliver outcomes to patients and establish a new standard of surgery. It operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. It is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. It is also working to incorporate all of this in the LUNA Surgical System.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
0.249 USD
Average target price
0.35 USD
Spread / Average Target
+40.56%
Consensus